Surveys 192 senior TMT, Life Sciences & Consumer/Industrial Products company executives on current risk management issues & practice.
Deloitte/Forbes Insights Executive Survey, May 2012 I 20 pages
Life Sciences
For the last decade, life sciences companies have faced many challenges: expiry of patents, price competition from generic producers, a rising cost base, low productivity in research and development, ongoing talent shortages, and challenges to their corporate reputations, to name a few. In such a daunting environment, it is clear that companies may need to transform in order to remain high-value-added innovators — and avoid becoming lower-margin suppliers.
Our industry specialists from across Deloitte provide an extensive depth of knowledge on the range of current issues experienced by the pharmaceuticals, biotechnology and medical device industries.
For case studies or examples of specific issues tackled and benefits gained please contact our team.
